Literature DB >> 36148085

Gaps and challenges in the management of atrial fibrillation in the Philippines.

Jeremy A Ceriales1, Leslie Faye T Cando1, Maria Llaine J Callanta2, Ourlad Alzeus G Tantengco1.   

Abstract

Entities:  

Year:  2022        PMID: 36148085      PMCID: PMC9486434          DOI: 10.1016/j.amsu.2022.104586

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


× No keyword cloud information.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. Chen and colleagues reported a 0.88% prevalence of AF in Shanghai, China. The associated risk factors include older age, female sex (>80 years), male sex (<80 years), and cardiovascular diseases [1]. The prevalence of AF is predicted to increase due to the increasing aging population and social industrialization, especially in developing countries. In this study, we share the epidemiology of AF in the Philippines, a developing country in Southeast Asia. Even though AF is the most common sustained arrhythmia, data on AF in the Philippines remains scarce [2]. The prevalence of AF in SEA is estimated to range from 2.6 to 23.04% [3]. Projections from available prevalence data predict that Asia will see a rapid increase in AF burden to an estimated 8.3 million by 2050. Structural heart diseases such as heart failure and valvular heart disease, especially rheumatic heart disease in developing countries, are common underlying causes of AF in Asia. Hyperthyroidism, CKD, obesity, OSA, diabetes, and hypertension also increase the risk of AF in Asians [2]. As AF substantially increases the occurrence of stroke by 4 to 5-fold, it is of utmost importance to adhere to a therapeutic plan. Management of patients is currently patterned to Western practice guidelines. Recommendations from the (ESC) promote an integrated therapeutic plan for AF, which include rhythm and rate control, stroke prevention, and management of comorbidities through lifestyle modifications, healthcare/patient education, and psychosocial support [4]. ESC recommends oral anticoagulants (VKAs or NOACs) to patients with risk factors for stroke by CHA2DS2-VASc score with INR monitoring. The use of antiplatelet is not highly recommended for stroke prevention in AF [5]. AF causes a significant burden to patients, physicians, and healthcare systems globally [4]. Management of the risk factors of AF is of prime importance in addressing the burden of AF in the Philippines. Management is multidisciplinary and multifaceted—lifestyle modifications, pharmacologic, and non-pharmacologic interventions. Screening and interventions should be more accessible and affordable since risk factors for AF are easily recognizable and manageable. More local research on AF should be done to raise public awareness and forward health programs. Guidelines should be personalized to Filipinos through research and collaborative efforts. To address these gaps and challenges, we call on the government to increase its attention and fund allocation to the health and research sectors in the Philippines.

Ethical approval

Not applicable.

Please state any sources of funding for your research

This study did not receive any funding.

Author contribution

All authors contributed equally in writing this manuscript.

Please state any conflicts of interest

We declare no competing interests.

Consent

Not applicable.

Registration of research studies

Name of the registry: Not applicable Unique Identifying number or registration ID: Not applicable Hyperlink to your specific registration (must be publicly accessible and will be checked): Not applicable

Guarantor

Jeremy A. Ceriales, BSc, Leslie Faye T. Cando, BSc, Maria Llaine J. Callanta, MD, PhD, MPM, *Ourlad Alzeus G. Tantengco, MD, PhD.
  3 in total

1.  Epidemiology, management, and outcomes of atrial fibrillation among 30 million citizens in Shanghai, China from 2015 to 2020: A medical insurance database study.

Authors:  Mu Chen; Cheng Li; Peng Liao; Xin Cui; Wenqi Tian; Qunshan Wang; Jian Sun; Mei Yang; Li Luo; Hong Wu; Yi-Gang Li
Journal:  Lancet Reg Health West Pac       Date:  2022-05-03

Review 2.  Stroke prevention in atrial fibrillation--an Asian stroke perspective.

Authors:  Hung-Fat Tse; Yong-Jun Wang; Moheeb Ahmed Ai-Abdullah; Annette B Pizarro-Borromeo; Chern-En Chiang; Rungroj Krittayaphong; Balbir Singh; Amit Vora; Chun-Xue Wang; Mohammad Zubaid; Andreas Clemens; Paul Lim; Dayi Hu
Journal:  Heart Rhythm       Date:  2013-03-15       Impact factor: 6.343

3.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Authors:  Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins
Journal:  Eur Heart J       Date:  2021-02-01       Impact factor: 29.983

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.